These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15616802)

  • 1. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
    Costacou T; Zgibor JC; Evans RW; Otvos J; Lopes-Virella MF; Tracy RP; Orchard TJ
    Diabetologia; 2005 Jan; 48(1):41-8. PubMed ID: 15616802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
    Costacou T; Lopes-Virella MF; Zgibor JC; Virella G; Otvos J; Walsh M; Orchard TJ
    J Diabetes Complications; 2005; 19(4):183-93. PubMed ID: 15993351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants and coronary artery disease among individuals with type 1 diabetes: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Costacou T; Zgibor JC; Evans RW; Tyurina YY; Kagan VE; Orchard TJ
    J Diabetes Complications; 2006; 20(6):387-94. PubMed ID: 17070445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Orchard TJ; Olson JC; Erbey JR; Williams K; Forrest KY; Smithline Kinder L; Ellis D; Becker DJ
    Diabetes Care; 2003 May; 26(5):1374-9. PubMed ID: 12716791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects.
    Hadjadj S; Aubert R; Fumeron F; Pean F; Tichet J; Roussel R; Marre M; ;
    Diabetologia; 2005 Jun; 48(6):1088-92. PubMed ID: 15875155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and future coronary heart disease events among men with type 2 diabetes.
    Schulze MB; Shai I; Rimm EB; Li T; Rifai N; Hu FB
    Diabetes; 2005 Feb; 54(2):534-9. PubMed ID: 15677512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low plasma adiponectin levels predict progression of coronary artery calcification.
    Maahs DM; Ogden LG; Kinney GL; Wadwa P; Snell-Bergeon JK; Dabelea D; Hokanson JE; Ehrlich J; Eckel RH; Rewers M
    Circulation; 2005 Feb; 111(6):747-53. PubMed ID: 15699257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women.
    Lawlor DA; Davey Smith G; Ebrahim S; Thompson C; Sattar N
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5677-83. PubMed ID: 16076942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetes.
    Natarajan A; Marshall SM; Kesteven PJ; McComb JM; Rutter MK
    Diabet Med; 2011 Oct; 28(10):1201-5. PubMed ID: 21480978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population.
    Aguilera E; Serra-Planas E; Granada ML; Pellitero S; Reverter JL; Alonso N; Soldevila B; Mauricio D; Puig-Domingo M
    Cardiovasc Diabetol; 2015 Sep; 14():121. PubMed ID: 26382922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of serum adiponectin in persons with and without type 1 diabetes.
    Maahs DM; Ogden LG; Snell-Bergeon JK; Kinney GL; Wadwa RP; Hokanson JE; Dabelea D; Kretowski A; Eckel RH; Rewers M
    Am J Epidemiol; 2007 Sep; 166(6):731-40. PubMed ID: 17591595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes.
    Morales A; Wasserfall C; Brusko T; Carter C; Schatz D; Silverstein J; Ellis T; Atkinson M
    Diabetes Care; 2004 Aug; 27(8):2010-4. PubMed ID: 15277432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.
    Frystyk J; Berne C; Berglund L; Jensevik K; Flyvbjerg A; Zethelius B
    J Clin Endocrinol Metab; 2007 Feb; 92(2):571-6. PubMed ID: 17119002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than nondiabetic subjects.
    Ezenwaka CE; Kalloo R
    Neth J Med; 2005 Feb; 63(2):64-9. PubMed ID: 15766010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower-extremity arterial calcification as a correlate of coronary artery calcification.
    Costacou T; Huskey ND; Edmundowicz D; Stolk R; Orchard TJ
    Metabolism; 2006 Dec; 55(12):1689-96. PubMed ID: 17142145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma adiponectin levels and risk of myocardial infarction in men.
    Pischon T; Girman CJ; Hotamisligil GS; Rifai N; Hu FB; Rimm EB
    JAMA; 2004 Apr; 291(14):1730-7. PubMed ID: 15082700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.
    Choi KM; Lee J; Lee KW; Seo JA; Oh JH; Kim SG; Kim NH; Choi DS; Baik SH
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):75-80. PubMed ID: 15212647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2.
    Schäffler A; Herfarth H; Paul G; Ehling A; Müller-Ladner U; Schölmerich J; Zietz B
    Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):383-9. PubMed ID: 15239024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.